Public Profile

Catalent

Catalent, Inc., a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products, is headquartered in the United States. Founded in 2007, Catalent has rapidly expanded its operations across North America, Europe, and Asia, establishing a strong presence in the pharmaceutical and biotechnology industries. The company is renowned for its innovative services, including drug formulation, clinical supply, and commercial manufacturing, which are designed to enhance product performance and patient experience. Catalent's commitment to quality and efficiency has positioned it as a trusted partner for many of the world's top pharmaceutical companies. With a focus on continuous improvement and cutting-edge technology, Catalent remains at the forefront of the industry, achieving significant milestones in drug delivery and development.

DitchCarbon Score

How does Catalent's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

46

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Catalent's score of 46 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Catalent's reported carbon emissions

In 2022, Catalent, headquartered in the US, reported total greenhouse gas emissions of approximately 92000000 kg CO2e for Scope 1 and about 40000000 kg CO2e for Scope 2. The combined emissions for Scope 1 and 2 amounted to around 132000000 kg CO2e. Notably, Scope 3 emissions were significantly higher, totalling approximately 718400000 kg CO2e, with the largest contributions from purchased goods and services (about 498800000 kg CO2e) and employee commuting (approximately 45400000 kg CO2e). Catalent has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the baseline. Additionally, the company plans to cut Scope 3 emissions related to fuel- and energy-related activities and employee commuting by 25% within the same timeframe. Furthermore, Catalent is committed to ensuring that 70% of its suppliers, based on emissions, will have science-based targets by FY2028. These initiatives align with industry standards for climate action and demonstrate Catalent's dedication to sustainability in the pharmaceuticals, biotechnology, and life sciences sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192020202120222023
Scope 1
61,000,000
00,000,000
00,000,000
00,000,000
000,000,000
Scope 2
144,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Catalent's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Catalent is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Catalent is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Charles River Laboratories

US
Research and development services (73)
Updated 10 days ago

Labcorp Drug Development Inc.

US
Research and development services (73)
Updated about 2 months ago
DitchCarbon Score

Porton Pharma Solutions

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Viatris

US
Chemicals nec
Updated 4 days ago

Shanghai SynTheAll Pharmaceutical Co., Ltd.

CN
Chemicals nec
Updated 30 days ago
DitchCarbon Score

Eurofins Scientific

LU
Other business services (74)
Updated about 13 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers